China Universal Asset Management Company’s Ligand Pharmaceuticals LGND Stock Holding History

China Universal Asset Management Company's LGND Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ligand Pharmaceuticals (LGND) stake by 9.9% in Q2 2026, selling an estimated $82.2K and leaving 3,190 shares worth $1.01M. The position accounts for 0.06% of the portfolio, ranked #203.

China Universal Asset Management Company first reported a position in LGND in Q3 2022 and has held it in 16 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

• China Universal Asset Management Company held 3,190 shares of Ligand Pharmaceuticals worth $1.01M as of Q2 2026.
• China Universal Asset Management Company sold 349 Ligand Pharmaceuticals shares in Q2 2026, an estimated $82.2K.
• Ligand Pharmaceuticals made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #203 holding.
• China Universal Asset Management Company first reported a position in Ligand Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
• 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.